Multisite Health-Systems Specialty Pharmacy Study Evaluates Adherence to Self-Administered Biologic Disease-Modifying Antirheumatic Drugshttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-news-round-1.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
High adherence to treatment is a key first step toward better patient outcomes, including sustained disease control or remission. Adherence to self-administered biologic disease-modifying antirheumatic drugs (bDMARDs) is a key…